about us

history

At IMU, we believe that the immune system is the most powerful biological system governing health and disease. Harnessing its power has the potential to radically advance how we cure disease and illness. Yet despite huge strides in immunology, much remains unknown about this intricate and dynamic system. It is massively complex with huge variation across individuals. Current tools and approaches to understand it at the level of detail and scale required to be meaningful were lacking. 

IMU’s mission is to revolutionize this field by developing a groundbreaking, population-scale systems-level understanding of the immune system. By harnessing the power of AI with deep system level immune profiling, we are creating tools that offer unprecedented insights into disease and health, driving forward the future of precision medicine.

The IMU platform is based on 10 years of research at King’s College London and the Francis Crick Institute. The technology was first applied during the covid-19 pandemic when the company’s co-founders leveraged the technology to understand the human immune response to the virus. The project was very successful and showed the need to apply the technology across a host of different illnesses, to transform how we approach health and disease.